Solventum Corp reported $1.05B in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Align Technology USD 228.16M 15.59M Sep/2025
Baxter International USD 2.23B 228M Dec/2025
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Cencora USD 24.08B 3.59B Dec/2025
Dexcom USD 629.1M 25M Dec/2025
Insulet USD 452.6M 6.3M Dec/2025
Solventum Corp USD 1.05B 87M Sep/2025
West Pharmaceutical Services USD 443.9M 5.9M Dec/2025
Zimmer Biomet Holdings USD 2.29B 197.3M Dec/2025